Can-Fite BioPharma CANF SEC Filings

NYSE CANF
$2.22 -0.07 (-3.06%)
As of: Sep 9, 2026 · 3:58 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Can-Fite BioPharma Ltd. (CANF) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index